Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)
Historic Receivables - Net for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $13.0 billion.
- Universe Pharmaceuticals' Receivables - Net fell 11.17% to $13.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 billion, marking a year-over-year decrease of 11.17%. This contributed to the annual value of $13.0 billion for FY2025, which is 11.17% down from last year.
- Universe Pharmaceuticals' Receivables - Net amounted to $13.0 billion in Q3 2025, which was down 11.17% from $13.0 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Receivables - Net's 5-year high stood at $13.0 billion during Q3 2024, with a 5-year trough of $11.0 million in Q3 2023.
- Moreover, its 5-year median value for Receivables - Net was $16.7 million (2022), whereas its average is $3.3 billion.
- As far as peak fluctuations go, Universe Pharmaceuticals' Receivables - Net plummeted by 9999.99% in 2021, and later skyrocketed by 11829320.85% in 2024.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Receivables - Net stood at $15.6 million in 2021, then rose by 2.58% to $16.0 million in 2022, then tumbled by 31.05% to $11.0 million in 2023, then skyrocketed by 118293.21% to $13.0 billion in 2024, then fell by 0.11% to $13.0 billion in 2025.
- Its Receivables - Net stands at $13.0 billion for Q3 2025, versus $13.0 billion for Q3 2024 and $14.4 million for Q1 2024.